(NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third ... “The payor innovation strategy continues to foster Medicare Advantage growth ...
PACS Group stock has dropped nearly 33% since Monday following a scathing report from a forensic financial firm that accused the newly public company of “scamming” the government and investors.
Topline data from pivotal Phase 3 TANDEM trial now expected in 4Q 2024 due to faster than expected enrollment – – On-track to report topline data from pivotal Phase 3 BROADWAY trial in 4Q 2024 – – ...